1. Diabetes Obes Metab. 2023 Oct;25(10):3071-3075. doi: 10.1111/dom.15188. Epub 
2023 Jun 29.

Urinary Î±1 microglobulin level is useful for selecting sodium-glucose 
transporter 2 inhibitor or metformin for visceral fat reduction in patients with 
type 2 diabetes.

Koshizaka M(1)(2)(3), Ishibashi R(2)(4), Ishikawa K(1)(2), Shoji M(1)(2), Ide 
K(1)(2), Ide S(1)(2), Kato H(1)(2), Teramoto N(1)(2), Terayama R(1)(2), Maezawa 
Y(1)(2), Yokote K(1)(2); PRIME-V Study Group.

Author information:
(1)Department of Medicine, Division of Diabetes, Metabolism and Endocrinology, 
Chiba University Hospital, Chiba, Japan.
(2)Department of Endocrinology, Hematology and Gerontology, Chiba University 
Graduate School of Medicine, Chiba, Japan.
(3)Center for Preventive Medical Sciences, Chiba University, Chiba, Japan.
(4)Department of Medicine, Division of Diabetes, Endocrinology and Metabolism, 
Kimitsu Chuo Hospital, Chiba, Japan.

DOI: 10.1111/dom.15188
PMID: 37385959 [Indexed for MEDLINE]
